SKINConsumer Defensive · Household & Personal ProductsThe 9 Wall Street analysts covering Skinhealth Systems, Inc. hold a median 12-month price target of $13 — +12.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 80 of 100 as at 22 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Skinhealth Systems, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (94): Reported profit is backed by cash, and the company is not expanding recklessly.
Volatility (20): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on SKIN, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
The green dot is the last close — the median target sits +12.7% from it.
Of the 20 most recent actions, 1 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 19 Oct 2026 | Jefferies | Maintains | Hold | $0.85 → $11 |
| 12 Aug 2026 | TD Cowen | Maintains | Hold | $1.00 → $0.90 |
| 12 Aug 2026 | TD Cowen | Maintains | Hold | — |
| 20 May 2026 | Roth Capital | Reiterates | Buy | $2.50 → $2.00 |
| 20 May 2026 | Roth Capital | Reiterates | Buy | — |
| 1 May 2026 | Canaccord Genuity | Maintains | Hold | — |
| 16 Mar 2026 | TD Cowen | Maintains | Hold | — |
| 13 Mar 2026 | Canaccord Genuity | Maintains | Hold | — |
| 21 Jan 2026 | TD Cowen | Maintains | Hold | — |
| 14 Jan 2026 | Jefferies | Assumes | Hold | $1.60 |
| 22 Sept 2025 | TD Cowen | Maintains | Hold | — |
| 19 Sept 2025 | Roth Capital | Initiates | Buy | — |
| 1 Aug 2025 | Stifel | Maintains | Hold | — |
| 5 May 2025 | Canaccord Genuity | Maintains | Hold | — |
| 13 Mar 2025 | Canaccord Genuity | Maintains | Hold | — |
| 13 Nov 2024 | Canaccord Genuity | Maintains | Hold | — |
| 12 Aug 2024 | Canaccord Genuity | Maintains | Hold | — |
| 9 Aug 2024 | Piper Sandler | Reiterates | Underweight | — |
| 26 July 2024 | Stifel | Maintains | Hold | — |
| 11 July 2024 | Piper Sandler | Maintains | Underweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
SKIN appears in the Radar on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 99% of US stocks
Cheaper than 90% of US stocks
Cheaper than 62% of US stocks
Cheaper than 31% of US stocks
Higher than 17% of US stocks
Higher than 28% of US stocks
Higher than 81% of US stocks
Higher than 55% of US stocks
Higher than 20% of US stocks
Higher than 23% of US stocks
Higher than 41% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Skinhealth Systems, Inc. has a market value of $71.8M and an enterprise value of $234.7M.
Revenue in the twelve months to 30 June 2026: $290.0M. The latest quarter shrank 7.8% year on year.
Net income over the same four quarters: −$28.4M, a −9.8% net margin.
Diluted earnings per share, trailing twelve months: $−0.22.
Free cash flow in the twelve months to 30 June 2026: $16.6M.
Trailing P/E: −135.7×; forward P/E: 2.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Skinhealth Systems, Inc. employs 613 people — $473K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Skinhealth Systems, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
SkinHealth Systems Inc. will report its third-quarter 2026 financial results after market close on November 5, 2026, and host a conference call and webcast.
Why it matters — SKIN watchers may follow the scheduled results and company discussion for updates on the quarter.
SkinHealth Systems (SKIN) shares rose 9.0% in the latest session on above-average trading volume. The excerpt says recent earnings estimate revisions do not suggest further strength ahead.
Why it matters — SKIN watchers may note the sharp session gain alongside the excerpt’s cautionary signal from earnings estimate revisions.
SkinHealth Systems announced that its board approved a 1-for-20 reverse stock split of the company’s Class A common stock.
Why it matters — SKIN watchers may note the board-approved change to the company’s Class A share structure.
Hydrafacial introduced HydraClear™, a triple-acid treatment booster designed to clarify and balance blemish-prone skin, fade visible signs of blemishes, and help maintain hydration.
Why it matters — The product introduction is relevant to SKIN watchers because it adds a treatment booster to Hydrafacial’s offerings for blemish-prone skin.
SkinHealth Systems (Nasdaq: SKIN), the company behind Hydrafacial™, announced the European expansion of its SkinStylus® SteriLock® MicroSystem, a professional microneedling and nano-needling device intended for cosmetic use.
Why it matters — A SKIN watcher would care because expanding the professional device portfolio into Europe broadens the company's international market presence for its flagship-brand-adjacent systems.
The 9 Wall Street analysts covering Skinhealth Systems, Inc. have a median 12-month price target of $13, with estimates ranging from $10 to $30. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering Skinhealth Systems, Inc., 1 rate it a Buy, 6 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks Skinhealth Systems, Inc. 80 out of 100 across roughly 4,600 US stocks as at 22 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Oct 2026, Skinhealth Systems, Inc. ranks 80 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (94 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +12.7% from the last close, and Ticker Nerd's factor model ranks Skinhealth Systems, Inc. 80 out of 100 as at 22 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Skinhealth Systems, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SKIN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $30 over the next 12 months.
SkinHealth Systems Inc. Class A Common Stock represents equity in SkinHealth Systems Inc., a global medical aesthetics company focused on professional skin-care and treatment technologies.
The most recent item we track (GlobeNewsWire, 22 Oct 2026): "SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026". SkinHealth Systems Inc. will report its third-quarter 2026 financial results after market close on November 5, 2026, and host a conference call and webcast.
SkinHealth Systems Inc. Class A Common Stock represents equity in SkinHealth Systems Inc., a global medical aesthetics company focused on professional skin-care and treatment technologies. SkinHealth Systems develops and markets an integrated portfolio centered on HydraFacial, its flagship skin treatment platform, alongside complementary offerings such as SkinStylus microneedling and HydraScalp with Keravive. The company serves clinics and providers through devices, consumables, and clinically validated treatment systems designed for use in aesthetic and dermatology-focused practices. Its products are distributed across multiple international regions, supporting a broad professional network in the skin-health market. SkinHealth Systems Inc. is headquartered in Long Beach, California, and its Class A Common Stock gives investors exposure to a business operating at the intersection of medical aesthetics, skincare technology, and provider-based treatment services.
CEO Mr. Pedro Malha · 613 employees · United States · https://www.skinhealthsystems.com